Skip to content

The Archive · A Source

FDA Expands Approval of Intranasal Esketamine Therapy (Spravato)

UTHealth Houston January 22, 2025 med.uth.edu/psychiatry/2025/01/22/fda-expands-approval-of-intranasal-esketamine-therapy-spravato